Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Inventory Average for 4 consecutive years, with $7.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Inventory Average rose 115.57% year-over-year to $7.1 million; the TTM figure through Jun 2026 stood at $7.1 million (up 115.57% YoY), while the FY2025 annual figure was $4.4 million, up 97.6% from the prior year.
• Inventory Average rose to $7.1 million in Q2 2026 per PHAT's latest filing, from $6.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $7.1 million in Q2 2026 and bottomed at $111000.0 in Q3 2023.
• Historically, Inventory Average has averaged $3.1 million across 4 years, with a median of $3.2 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory Average surged 2281.98% — and 2025, when it soared 33.17%.
• Phathom Pharmaceuticals' Inventory Average stood at $659500.0 in 2023, then surged by 379.08% to $3.2 million in 2024, then soared by 44.47% to $4.6 million in 2025, then jumped by 55.78% to $7.1 million in 2026.
• Business Quant data shows PHAT's Inventory Average at $7.1 million in Q2 2026, $6.0 million in Q1 2026, and $4.6 million in Q4 2025.